Seattle, WA, United States of America

David Andrew Martin

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2014-2022

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: David Andrew Martin: Innovator in Pharmaceutical Formulations

Introduction

David Andrew Martin is a notable inventor based in Seattle, WA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibody formulations for disease treatment. With a total of four patents to his name, Martin's work has the potential to impact therapeutic practices significantly.

Latest Patents

Among his latest patents is a method of treating diseases using an IL-17 receptor antibody formulation. This patent relates to AM-14 pharmaceutical formulations and therapeutic dosing regimens aimed at treating various diseases. Another patent focuses on the IL-17 receptor antibody formulation, which also pertains to AM-14 and its therapeutic applications.

Career Highlights

David Andrew Martin has worked with prominent companies in the pharmaceutical industry, including Kirin-Amgen, Inc. and Amgen K.A., Inc. His experience in these organizations has contributed to his expertise in developing innovative treatments.

Collaborations

Throughout his career, Martin has collaborated with talented individuals such as Dingjiang Liu and Holly Zhuohong Huang. These partnerships have likely enhanced his research and development efforts.

Conclusion

David Andrew Martin's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical treatments. His patents reflect a dedication to improving health outcomes through scientific research and collaboration.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…